Drug Profile
Research programme: c-MET inhibitor - Biocad
Alternative Names: Anti c-METLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Biocad
- Class Antineoplastics
- Mechanism of Action Proto-oncogene protein c-met inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Cancer in Russia